First National Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
3,235
-4,663
| -59% | -$1.89M | 0.19% | 120 |
|
|
2025
Q1 | $3.93M | Sell |
7,898
-55
| -0.7% | -$27.4K | 0.63% | 44 |
|
|
2024
Q4 | $4.14M | Sell |
7,953
-838
| -10% | -$436K | 0.67% | 37 |
|
|
2024
Q3 | $5.44M | Buy |
8,791
+412
| +5% | +$255K | 0.87% | 24 |
|
|
2024
Q2 | $4.63M | Buy |
8,379
+1,311
| +19% | +$725K | 0.85% | 25 |
|
|
2024
Q1 | $4.1M | Buy |
7,068
+856
| +14% | +$496K | 0.92% | 23 |
|
|
2023
Q4 | $3.3M | Buy |
6,212
+1,933
| +45% | +$1.03M | 0.95% | 23 |
|
|
2023
Q3 | $2.17M | Buy |
4,279
+1,773
| +71% | +$897K | 0.97% | 22 |
|
|
2023
Q2 | $1.31M | Buy |
2,506
+125
| +5% | +$65.2K | 1.2% | 22 |
|
|
2023
Q1 | $1.37M | Buy |
2,381
+175
| +8% | +$101K | 1.56% | 15 |
|
|
2022
Q4 | $1.22M | Buy |
2,206
+237
| +12% | +$131K | 1.56% | 17 |
|
|
2022
Q3 | $999K | Buy |
1,969
+554
| +39% | +$281K | 1.48% | 11 |
|
|
2022
Q2 | $769K | Buy |
+1,415
| New | +$769K | 1.6% | 10 |
|